-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics announces annual shareholder meeting

PUBT·04/24/2026 21:02:37
Listen to the news
Aquestive Therapeutics announces annual shareholder meeting
  • Aquestive Therapeutics schedules 2026 annual stockholders meeting for June 10, 2026 in virtual-only format.
  • Shareholders will vote on election of three Class II directors.
  • Meeting agenda includes advisory vote on named executive officer compensation.
  • Investors will also vote on ratification of KPMG as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-016757), on April 24, 2026, and is solely responsible for the information contained therein.